Optimal Dosing for Targeted Therapies in Oncology: Drug Development Cases Leading by Example
Year: 2015
Type: review
Source: Clinical Cancer Research
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2173235643
